Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Necrotizing pancreatitis due to hypercalcemia in a hemodialysis patient with pica.

Brener ZZ, Bergman M.

Clin Kidney J. 2014 Aug;7(4):399-401. doi: 10.1093/ckj/sfu065. Epub 2014 Jun 23.

2.

Prolonged international normalized ratio during the first year of warfarin treatment.

Bergman M, Dicker D, Blumberger N, Brener ZZ, Ori Y, Salman H.

Am J Med Sci. 2014 Jul;348(1):71-4. doi: 10.1097/MAJ.0000000000000209.

PMID:
24949726
3.

A study of elderly adults taking warfarin admitted with prolonged international normalized ratio: a community hospital's experience.

Bergman M, Ori Y, Blumberger N, Brener ZZ, Salman H.

J Am Geriatr Soc. 2012 Sep;60(9):1713-7. doi: 10.1111/j.1532-5415.2012.04103.x. Epub 2012 Aug 6.

PMID:
22880717
4.

Nephrolithiasis: evaluation and management.

Brener ZZ, Winchester JF, Salman H, Bergman M.

South Med J. 2011 Feb;104(2):133-9. doi: 10.1097/SMJ.0b013e318206f6bd. Review.

PMID:
21258231
5.

The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients.

Brener ZZ, Thijssen S, Kotanko P, Kuhlmann MK, Bergman M, Winchester JF, Levin NW.

Blood Purif. 2011;31(4):243-51. doi: 10.1159/000322252. Epub 2011 Jan 14.

PMID:
21242677
6.

Acute liver failure following hemodialysis arteriovenous graft placement: a case report.

Brener ZZ, Paiusco AD, Bergman M.

J Med Case Rep. 2010 Aug 10;4:261. doi: 10.1186/1752-1947-4-261.

7.

Recovery of transient pericardial constriction following steroid administration.

Samara A, Bergman M, Vitrai J, Brener ZZ, Salman H.

Heart Lung Circ. 2010 Aug;19(8):470-2. doi: 10.1016/j.hlc.2010.04.131. Epub 2010 Jun 11.

PMID:
20541970
8.

Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians.

Brener ZZ, Kotanko P, Thijssen S, Winchester JF, Bergman M.

Am J Med Sci. 2010 May;339(5):453-6. doi: 10.1097/MAJ.0b013e3181cf7d5b. Review.

PMID:
20375877
9.

Rhabdomyolysis following clarithromycin monotherapy.

Brener ZZ, Bilik I, Khorets B, Winchester JF, Bergman M.

Am J Med Sci. 2009 Jul;338(1):78. doi: 10.1097/MAJ.0b013e31819e221f.

PMID:
19474653
10.

Acute kidney injury in a patient with nontuberculous mycobacterial infections: a case report.

Brener ZZ, Zhuravenko I, Bergman M.

Cases J. 2009 Jan 23;2(1):83. doi: 10.1186/1757-1626-2-83.

11.

Acute non-occlusive mesenteric ischemia of the small bowel in a patient started on hemodialysis: a case report.

Brener ZZ, Bergman M, Ohm HK, Winchester JF.

Cases J. 2008 Oct 6;1(1):217. doi: 10.1186/1757-1626-1-217.

12.
13.

An unusual presentation of renal cell carcinoma with late metastases to the small intestine, thyroid gland, nose and skull base.

Brener ZZ, Zhuravenko I, Jacob CE, Bergman M.

Nephrol Dial Transplant. 2007 Mar;22(3):930-2. Epub 2007 Jan 8. No abstract available.

PMID:
17210603
14.

Acute renal failure in a patient with West Nile viral encephalitis.

Brener ZZ, Harbord NB, Zhuravenko I, Nicastri AD, Bergman M, Dubrow A, Feinfeld D, Winchester J.

Nephrol Dial Transplant. 2007 Feb;22(2):662-3. Epub 2006 Sep 30. No abstract available.

PMID:
17012739
15.

Effect of ultrafiltration on thermal variables, skin temperature, skin blood flow, and energy expenditure during ultrapure hemodialysis.

van der Sande FM, Rosales LM, Brener Z, Kooman JP, Kuhlmann M, Handelman G, Greenwood RN, Carter M, Schneditz D, Leunissen KM, Levin NW.

J Am Soc Nephrol. 2005 Jun;16(6):1824-31. Epub 2005 Apr 27.

16.

Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains.

Urbina JA, Payares G, Sanoja C, Molina J, Lira R, Brener Z, Romanha AJ.

Int J Antimicrob Agents. 2003 Jan;21(1):39-48.

PMID:
12507836
17.

Online monitoring of cerebral hemodynamics during hemodialysis.

Metry G, Spittle M, Rahmati S, Giller C, Giller A, Kaufman A, Schneditz D, Manno E, Brener Z, Boniece I, Ronco F, Ronco C, Levin NW.

Am J Kidney Dis. 2002 Nov;40(5):996-1004.

PMID:
12407645
18.

Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease.

Martins-Filho OA, Eloi-Santos SM, Teixeira Carvalho A, Oliveira RC, Rassi A, Luquetti AO, Rassi GG, Brener Z.

Clin Diagn Lab Immunol. 2002 Sep;9(5):1107-13.

19.

ANCA-associated vasculitis in Greek siblings with chronic exposure to silica.

Brener Z, Cohen L, Goldberg SJ, Kaufman AM.

Am J Kidney Dis. 2001 Nov;38(5):E28.

PMID:
11684580
20.

Cure of experimental Chagas' disease by the bis-triazole DO870 incorporated into 'stealth' polyethyleneglycol-polylactide nanospheres.

Molina J, Urbina J, Gref R, Brener Z, Rodrigues Júnior JM.

J Antimicrob Chemother. 2001 Jan;47(1):101-4.

PMID:
11152439
21.

In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi.

Molina J, Brener Z, Romanha AJ, Urbina JA.

J Antimicrob Chemother. 2000 Jul;46(1):137-40.

PMID:
10882704
22.

A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease.

Araújo MS, Martins-Filho OA, Pereira ME, Brener Z.

J Antimicrob Chemother. 2000 Jun;45(6):819-24.

PMID:
10837436
23.

Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively.

Dutra WO, Colley DG, Pinto-Dias JC, Gazzinelli G, Brener Z, Pereira ME, Coffman RL, Correa-Oliveira R, Carvalho-Parra JF.

Scand J Immunol. 2000 Jan;51(1):91-7.

24.
25.

Interleukin-12 enhances in vivo parasiticidal effect of benznidazole during acute experimental infection with a naturally drug-resistant strain of Trypanosoma cruzi.

Michailowsky V, Murta SM, Carvalho-Oliveira L, Pereira ME, Ferreira LR, Brener Z, Romanha AJ, Gazzinelli RT.

Antimicrob Agents Chemother. 1998 Oct;42(10):2549-56.

26.

Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox.

Murta SM, Gazzinelli RT, Brener Z, Romanha AJ.

Mol Biochem Parasitol. 1998 Jun 1;93(2):203-14.

PMID:
9662705
27.

Trypanosoma cruzi genome project: biological characteristics and molecular typing of clone CL Brener.

Zingales B, Pereira ME, Oliveira RP, Almeida KA, Umezawa ES, Souto RP, Vargas N, Cano MI, da Silveira JF, Nehme NS, Morel CM, Brener Z, Macedo A.

Acta Trop. 1997 Nov;68(2):159-73.

PMID:
9386791
28.

Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease.

Brener Z, Gazzinelli RT.

Int Arch Allergy Immunol. 1997 Oct;114(2):103-10. Review.

PMID:
9338602
29.

Influence of parasite presence on the immunologic profile of peripheral blood mononuclear cells from chagasic patients after specific drug therapy.

Dutra WO, da Luz ZM, Cançado JR, Pereira ME, Brigido-Nunes RM, Galvão LM, Colley DG, Brener Z, Gazzinelli G, Carvalho-Parra JF.

Parasite Immunol. 1996 Nov;18(11):579-85.

PMID:
9226696
30.

Evaluation of the rabbit as a model for Chagas disease-II. Histopathologic studies of the heart, digestive tract and skeletal muscle.

da Silva AM, Eduardo Ramirez L, Vargas M, Chapadeiro E, Brener Z.

Mem Inst Oswaldo Cruz. 1996 Mar-Apr;91(2):199-206.

31.

Recrudescence induced by cyclophosphamide of chronic Trypanosoma cruzi infection in mice is influenced by the parasite strain.

Pereira ME, Santos LM, Araújo MS, Brener Z.

Mem Inst Oswaldo Cruz. 1996 Jan-Feb;91(1):71-4.

32.

Chagasic patients lack CD28 expression on many of their circulating T lymphocytes.

Dutra WO, Martins-Filho OA, Cançado JR, Pinto-Dias JC, Brener Z, Gazzinelli G, Carvalho JF, Colley DG.

Scand J Immunol. 1996 Jan;43(1):88-93.

PMID:
8560201
33.

Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.

Martins-Filho OA, Pereira ME, Carvalho JF, Cançado JR, Brener Z.

Clin Diagn Lab Immunol. 1995 Sep;2(5):569-73.

34.

Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease.

Dutra WO, Martins-Filho OA, Cançado JR, Pinto-Dias JC, Brener Z, Freeman Júnior GL, Colley DG, Gazzinelli G, Parra JC.

Int Immunol. 1994 Apr;6(4):499-506.

PMID:
8018591
35.

Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study.

Galvao LM, Nunes RM, Cançado JR, Brener Z, Krettli AU.

Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):220-3.

PMID:
8337734
36.

An experimental and clinical assay with ketoconazole in the treatment of Chagas disease.

Brener Z, Cançado JR, Galvão LM, da Luz ZM, Filardi Lde S, Pereira ME, Santos LM, Cançado CB.

Mem Inst Oswaldo Cruz. 1993 Jan-Mar;88(1):149-53.

37.
38.

Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies.

Gazzinelli RT, Pereira ME, Romanha A, Gazzinelli G, Brener Z.

Parasite Immunol. 1991 Jul;13(4):345-56.

PMID:
1717927
39.

Immunological aspects of the morbidity of human Chagas' disease.

Gazzinelli G, Brener Z.

Res Immunol. 1991 Feb;142(2):167-9. Review. No abstract available.

PMID:
1907756
40.
41.

Comparative studies of nifurtimox uptake and metabolism by drug-resistant and susceptible strains of Trypanosoma cruzi.

Tsuhako MH, Alves MJ, Colli W, Filardi LS, Brener Z, Augusto O.

Comp Biochem Physiol C. 1991;99(3):317-21.

PMID:
1685402
42.
43.

Two modes of idiotypic stimulation of T lymphocytes from patients with Chagas' disease: correlations with clinical forms of infection.

Gazzinelli RT, Gazzinelli G, Cançado JR, Cardoso JE, Brener Z, Colley DG.

Res Immunol. 1990 Oct;141(8):757-70.

PMID:
2128549
44.

Restricted bioreductive metabolism of a nitroimidazole-thiadiazole derivative with curative action in experimental Trypanosoma cruzi infections.

Tsuhako MH, Alves MJ, Colli W, Brener Z, Augusto O.

Biochem Pharmacol. 1989 Dec 15;38(24):4491-6.

PMID:
2513811
45.

Trypanosoma cruzi isoenzyme pattern as an epidemiological tool.

Romanha AJ, Brener Z.

Mem Inst Oswaldo Cruz. 1988 Nov;83 Suppl 1:383-6. Review. No abstract available.

46.

Anti-Trypanosoma cruzi and anti-laminin antibodies in chagasic patients after specific treatment.

Gazzinelli RT, Galvão LM, Cardoso JE, Cançado JR, Krettli AU, Brener Z, Gazzinelli G.

J Clin Microbiol. 1988 Sep;26(9):1795-800.

47.

Idiotype stimulation of T lymphocytes from Trypanosoma cruzi-infected patients.

Gazzinelli RT, Morato MJ, Nunes RM, Cançado JR, Brener Z, Gazzinelli G.

J Immunol. 1988 May 1;140(9):3167-72.

PMID:
3129512
48.

Anti-laminin and specific antibodies in acute Chagas disease.

Gazzinelli R, Galvão LM, Dias JC, Gazzinelli G, Brener Z.

Trans R Soc Trop Med Hyg. 1988;82(4):574-6.

PMID:
3151413
49.

Evaluation of the rabbit as a model for Chagas' disease. I. Parasitological studies.

Ramirez LE, Brener Z.

Mem Inst Oswaldo Cruz. 1987 Oct-Dec;82(4):531-6.

50.

Supplemental Content

Loading ...
Support Center